Innoveren Scientific Inc. (IVRN)
OTCMKTS
· Delayed Price · Currency is USD
0.0004
-0.0003 (-42.86%)
At close: Jan 14, 2026
Innoveren Scientific Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
| Cash & Equivalents | 0.54 | - | 0.1 | 1.64 | 1.42 | 0.07 |
| Cash & Short-Term Investments | 0.54 | - | 0.1 | 1.64 | 1.42 | 0.07 |
| Cash Growth | 1381.04% | - | -94.20% | 15.21% | 1945.29% | - |
| Accounts Receivable | 0.01 | 0.03 | 0.06 | - | 0.02 | 0.02 |
| Other Receivables | 0.06 | - | - | 0.02 | 0.02 | 0.01 |
| Receivables | 0.07 | 0.03 | 0.06 | 0.02 | 0.04 | 0.02 |
| Prepaid Expenses | 0.14 | 0.05 | 0.04 | 0.09 | 0.81 | 0.06 |
| Total Current Assets | 0.75 | 0.08 | 0.2 | 1.76 | 2.28 | 0.15 |
| Property, Plant & Equipment | 0.02 | 0.02 | 0.04 | 0.42 | 0.96 | 0.27 |
| Long-Term Accounts Receivable | 0.01 | 0.01 | 0.07 | - | - | - |
| Other Long-Term Assets | 0.02 | 0.02 | 0.02 | 0.03 | 0.04 | 0.04 |
| Total Assets | 0.79 | 0.14 | 0.32 | 2.2 | 3.27 | 0.45 |
| Accounts Payable | 1.26 | 0.97 | 0.59 | 1.01 | 1.49 | 0.88 |
| Accrued Expenses | 2.31 | 1.94 | 0.34 | 0.28 | 0.38 | 0.34 |
| Short-Term Debt | 4.32 | 3.76 | 3.33 | - | 2.06 | 0.18 |
| Current Portion of Long-Term Debt | 0.11 | 0.1 | 0.14 | 0.67 | 0.07 | - |
| Current Portion of Leases | 0.01 | 0.06 | 0.09 | 0.14 | 0.45 | - |
| Current Unearned Revenue | - | - | 0.41 | 0.63 | 1.05 | 0.33 |
| Other Current Liabilities | 1.66 | 0.64 | 0.03 | 0.15 | 0.28 | 0.46 |
| Total Current Liabilities | 9.66 | 7.48 | 4.92 | 2.89 | 5.77 | 2.19 |
| Long-Term Debt | - | - | - | 0.2 | 0.01 | 4.31 |
| Long-Term Leases | - | - | 0.06 | 0.16 | 0.3 | - |
| Other Long-Term Liabilities | 2.02 | 2.02 | - | - | 0.58 | 0.02 |
| Total Liabilities | 11.68 | 9.49 | 4.98 | 3.25 | 6.67 | 6.52 |
| Common Stock | 0 | 0 | 0.16 | 0.13 | 0.1 | 0.03 |
| Additional Paid-In Capital | 49.76 | 49.53 | 43.7 | 42.52 | 28.17 | 3.57 |
| Retained Earnings | -61.09 | -59.33 | -49.03 | -44.23 | -37.36 | -9.3 |
| Total Common Equity | -11.33 | -9.8 | -5.16 | -1.59 | -9.09 | -5.7 |
| Minority Interest | - | - | - | - | -0.37 | -0.37 |
| Shareholders' Equity | -10.89 | -9.36 | -4.66 | -1.05 | -3.4 | -6.07 |
| Total Liabilities & Equity | 0.79 | 0.14 | 0.32 | 2.2 | 3.27 | 0.45 |
| Total Debt | 4.44 | 3.92 | 3.62 | 1.17 | 2.89 | 4.49 |
| Net Cash (Debt) | -3.89 | -3.92 | -3.52 | 0.47 | -1.47 | -4.42 |
| Net Cash Per Share | -6.58 | -13.35 | -24.17 | 4.20 | -15.25 | -131.21 |
| Filing Date Shares Outstanding | 0.71 | 0.63 | 0.25 | 0.14 | 0.1 | 0.03 |
| Total Common Shares Outstanding | 0.71 | 0.62 | 0.16 | 0.13 | 0.1 | 0.03 |
| Working Capital | -8.91 | -7.39 | -4.72 | -1.14 | -3.5 | -2.04 |
| Book Value Per Share | -15.91 | -15.84 | -31.45 | -12.47 | -91.12 | -169.23 |
| Tangible Book Value | -11.33 | -9.8 | -5.16 | -1.59 | -9.09 | -5.7 |
| Tangible Book Value Per Share | -15.91 | -15.84 | -31.45 | -12.47 | -91.12 | -169.23 |
| Machinery | - | - | - | - | 0.48 | 0.43 |
| Leasehold Improvements | - | - | - | - | 0.16 | 0.16 |
Source: S&P Capital IQ. Standard template. Financial Sources.